Walleye Trading’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Walleye Trading’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,000	Closed	-$712	–	5653
2022 Q4	$712	Hold	40,000	–	–	﹤0.01%	4838
2022 Q3	$3K	Hold	40,000	–	–	﹤0.01%	4771
2022 Q2	$3K	Hold	40,000	–	–	﹤0.01%	4913
2022 Q1	$8K	Hold	40,000	–	–	﹤0.01%	5026
2021 Q4	$22K	Buy	+40,000	New	+$22.7K	﹤0.01%	4904

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Walleye Trading's IBER.WS Position: Q1 2023 in Review

Walleye Trading sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 40,000 shares — an estimated $712 sold.

Walleye Trading first reported a position in IBER.WS in Q4 2021 and held it in 5 quarters. The position peaked at $22K in Q4 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Walleye Trading reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 40,000 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $712.
Walleye Trading first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2021 and held it in 5 quarters.
Walleye Trading's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $22K in Q4 2021.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.